JB Capital lifts target for Logista stock to EUR 35.50
Published on 10/20/2026 at 10:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst valuation and operating scale
- JB Capital Markets raised its Logista target from EUR 33.70 to EUR 35.50 on October 13, 2026.
- Logista Pharma planned 6 million flu doses for delivery to 3,200 points on October 6, 2026.
- Logista stock trades at EUR 37.07 at 10:29 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.24 percent above the Xetra close of October 19, 2026.
Logista (ISIN ES0105027009) was trading at EUR 37.07 at Lang & Schwarz on October 20, 2026, at 10:29 a.m. CEST, 0.24 percent above the Xetra close of EUR 36.98 on October 19, 2026. On October 13, 2026, JB Capital Markets raised its target for Logista from EUR 33.70 to EUR 35.50 while keeping a neutral recommendation, as XTB reported. The target remains below the current euro quotation.
Pharma logistics adds operating scale
Logista Pharma launched its 2026 influenza vaccination campaign on October 6, 2026, planning almost 6 million doses for more than 3,200 supply points in Spain, according to Logista Pharma. Peak transport capacity is set to rise from 16 to more than 40 vehicles per day, an increase of more than 150 percent.
The campaign also includes a Madrid region COVID-19 service covering 840,320 doses and 206,720 vials at 900 delivery points under a contract extended through September 2027. These figures give investors a concrete view of the pharmaceutical unit's seasonal workload.
Three dates chart the recent picture
On July 24, 2026, Logista reported third-quarter revenue of EUR 3.57 billion and net income of EUR 74.0 million, with net income up 17 percent from the third quarter of 2025, according to Simply Wall St. On October 6, 2026, Logista Pharma announced its 6 million-dose campaign, and on October 13, 2026, JB Capital Markets lifted its target to EUR 35.50.
When will Logista report again?
Logista has scheduled its fiscal 2026 results for November 6, 2026, before the market opens, followed by an analyst and investor presentation at 10:00 a.m. CET, according to Investing.com. The upcoming release will provide the next full-year comparison for revenue, profit and operating performance.
Valuation meets a seasonal catalyst
The market quotation sits EUR 1.57 above JB Capital Markets' revised target, while the latest reported quarter showed EUR 3.57 billion in revenue and EUR 74.0 million in net income. The combination of a defined November reporting date and measurable pharmaceutical activity gives the stock a clear set of figures to track.
Logista was trading at EUR 37.07 at Lang & Schwarz on October 20, 2026, at 10:29 a.m. CEST, 0.24 percent above the Xetra close of EUR 36.98 on October 19, 2026. The further course of trading is shown by the continuously updated real-time quote of Logista stock.
Logista stock facts
- Company: Logista Integral, S.A.
- ISIN: ES0105027009
- WKN: A117Q0
- Ticker: 5CI
- Primary exchange: BME
- Price Lang & Schwarz (as of October 20, 2026, 10:29 a.m. CEST): EUR 37.07
- Change versus Xetra close: plus 0.24 percent
- Xetra close (October 19, 2026): EUR 36.98
- Market capitalization: EUR 4.9 billion (as of October 20, 2026)
- 52-week range: EUR 28.16-37.76 (as of October 20, 2026)
- Sector / Industry: Industrials / Integrated Freight & Logistics
- Next earnings date: November 6, 2026
Market context: Market report IBEX 35.
